Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Tuberculosis

Free Subscription Articles published in Eur J Clin Microbiol Infect Dis Retrieve available abstracts of 32 articles: HTML format

Single Articles

November 2021
1. PENG X, Liao Q, Fang M, Zhu Y, et al
   Detection of pulmonary tuberculosis in children using the Xpert MTB/RIF Ultra assay on sputum: a multicenter study.
   Eur J Clin Microbiol Infect Dis. 2021 Nov 4. pii: 10.1007/s10096-021-04340.
   PubMed     Abstract available
   
   
   August 2021
2. GAO J, Du J, Shu W, Liu Y, et al
   Stepwise selection of mutation conferring fluroquinolone resistance: multisite MDR-TB cohort study.
   Eur J Clin Microbiol Infect Dis. 2021;40:1767-1771.
   PubMed     Abstract available
   
   
   July 2021
3. PINHATA JMW, Brandao AP, Mendes FF, Rabello MCDS, et al
   Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting.
   Eur J Clin Microbiol Infect Dis. 2021 Jul 23. pii: 10.1007/s10096-021-04316.
   PubMed     Abstract available
   
   
   April 2021
4. HUANG C, Pan L, Shen X, Tian H, et al
   Hsp16.3 of mycobacterium tuberculosis in exosomes as a biomarker of tuberculosis.
   Eur J Clin Microbiol Infect Dis. 2021 Apr 24. pii: 10.1007/s10096-021-04246.
   PubMed     Abstract available
   
   
   
5. NKWAGATSE T, Sturm AW
   Affinity of Mycobacterium tuberculosis strains for M059K microglial cells after migration through A549 alveolar epithelium.
   Eur J Clin Microbiol Infect Dis. 2021 Apr 9. pii: 10.1007/s10096-021-04226.
   PubMed     Abstract available
   
   
   
6. LIANG J, An H, Zhou J, Liu Y, et al
   Exploratory development of PCR-fluorescent probes in rapid detection of mutations associated with extensively drug-resistant tuberculosis.
   Eur J Clin Microbiol Infect Dis. 2021 Apr 1. pii: 10.1007/s10096-021-04236.
   PubMed     Abstract available
   
   
   January 2021
7. MEIER T, Enders M
   High reproducibility of the interferon-gamma release assay T-SPOT.TB in serial testing.
   Eur J Clin Microbiol Infect Dis. 2021;40:85-93.
   PubMed     Abstract available
   
   
   November 2020
8. ZHENG H, Zhong F, Yu G, Shen Y, et al
   Comparison of the diagnostic efficacy of the CapitalBio Mycobacterium real-time polymerase chain reaction detection test and Xpert MTB/RIF in smear-negative pulmonary tuberculosis.
   Eur J Clin Microbiol Infect Dis. 2020 Nov 26. pii: 10.1007/s10096-020-04113.
   PubMed     Abstract available
   
   
   
9. CHEE CBE, Lim LKY, Ong RTH, Sng LH, et al
   Whole genome sequencing analysis of multidrug-resistant tuberculosis in Singapore, 2006-2018.
   Eur J Clin Microbiol Infect Dis. 2020 Nov 15. pii: 10.1007/s10096-020-04100.
   PubMed     Abstract available
   
   
   October 2020
10. KANG W, Du J, Yang S, Yu J, et al
    The prevalence and risks of major comorbidities among inpatients with pulmonary tuberculosis in China from a gender and age perspective: a large-scale multicenter observational study.
    Eur J Clin Microbiol Infect Dis. 2020 Oct 22. pii: 10.1007/s10096-020-04077.
    PubMed     Abstract available
    
    
    September 2020
11. LIU P, Wang Y, Hao S, Qin Y, et al
    Comparison of the CapitalBioMycobacterium RT-PCR detection test and Xpert MTB/RIF assay for diagnosis of renal tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2020 Sep 29. pii: 10.1007/s10096-020-04052.
    PubMed     Abstract available
    
    
    
12. PHAM TT, Schrenzel J, Janssens JP, Emonet S, et al
    Performances and usefulness of Xpert MTB/RIF assay in low-incidence settings: not that bad?
    Eur J Clin Microbiol Infect Dis. 2020;39:1645-1649.
    PubMed     Abstract available
    
    
    August 2020
13. KAMALI KAKHKI R, Najafzadeh MJ, Kachuei R, Ghazvini K, et al
    Targeting novel genes for simultaneous detection of five fungal and bacterial agents from BAL samples using multiplex PCR assay.
    Eur J Clin Microbiol Infect Dis. 2020;39:1535-1542.
    PubMed     Abstract available
    
    
    July 2020
14. CIESIELCZUK H, Kouvas N, North N, Buchanan R, et al
    Evaluation of the BD MAX MDR-TB assay in a real-world setting for the diagnosis of pulmonary and extra-pulmonary TB.
    Eur J Clin Microbiol Infect Dis. 2020;39:1321-1327.
    PubMed     Abstract available
    
    
    June 2020
15. FAN J, An J, Shu W, Huo F, et al
    Epidemiology of skeletal tuberculosis in Beijing, China: a 10-year retrospective analysis of data.
    Eur J Clin Microbiol Infect Dis. 2020 Jun 19. pii: 10.1007/s10096-020-03924.
    PubMed     Abstract available
    
    
    
16. MA Z, Ji X, Yang H, He J, et al
    Screening and evaluation of Mycobacterium tuberculosis diagnostic antigens.
    Eur J Clin Microbiol Infect Dis. 2020 Jun 16. pii: 10.1007/s10096-020-03951.
    PubMed     Abstract available
    
    
    April 2020
17. SFAIROPOULOS D, Tsiara S, Barkas F, Margariti PN, et al
    Is brucellosis a great mimic of tuberculosis? A case report.
    Eur J Clin Microbiol Infect Dis. 2020 Apr 24. pii: 10.1007/s10096-020-03902.
    PubMed     Abstract available
    
    
    March 2020
18. MENICHINI M, Lari N, Lupetti A, Rindi L, et al
    Evaluation of Xpert MTB/RIF Ultra assay for rapid diagnosis of pulmonary and extra-pulmonary tuberculosis in an Italian center.
    Eur J Clin Microbiol Infect Dis. 2020 Mar 31. pii: 10.1007/s10096-020-03867.
    PubMed    
    
    
    February 2020
19. UZORKA JW, Duinkerk DL, Kroft LJM, Bakker JA, et al
    Trends in diagnostic methods and treatment of latent tuberculosis infection in a tertiary care center from 2000 to 2017.
    Eur J Clin Microbiol Infect Dis. 2020 Feb 20. pii: 10.1007/s10096-020-03850.
    PubMed     Abstract available
    
    
    
20. LI J, Zhao A, Tang J, Wang G, et al
    Tuberculosis vaccine development: from classic to clinical candidates.
    Eur J Clin Microbiol Infect Dis. 2020 Feb 15. pii: 10.1007/s10096-020-03843.
    PubMed     Abstract available
    
    
    January 2020
21. SEMINARI E, Monzillo V, Lombardi A, Barbarini D, et al
    Migrations do not modify Mycobacterium tuberculosis resistance rates: a 20-year retrospective study.
    Eur J Clin Microbiol Infect Dis. 2020 Jan 24. pii: 10.1007/s10096-020-03820.
    PubMed     Abstract available
    
    
    
22. LOPEZ-ROA P, Aznar E, Cacho J, Cogollos-Agruna R, et al
    Epidemiology of Non-Tuberculous Mycobacteria isolated from clinical specimens in Madrid, Spain, from 2013 to 2017.
    Eur J Clin Microbiol Infect Dis. 2020 Jan 24. pii: 10.1007/s10096-020-03826.
    PubMed     Abstract available
    
    
    
23. DU J, Shu W, Liu Y, Wang Y, et al
    Multicenter feasibility study to assess external quality panels for molecular diagnostics for tuberculosis in China.
    Eur J Clin Microbiol Infect Dis. 2020 Jan 3. pii: 10.1007/s10096-019-03730.
    PubMed     Abstract available
    
    
    
24. SHU W, Du J, Liu Y, Wang Y, et al
    External quality control of phenotypic drug susceptibility testing for Mycobacterium tuberculosis in China.
    Eur J Clin Microbiol Infect Dis. 2020 Jan 2. pii: 10.1007/s10096-019-03770.
    PubMed     Abstract available
    
    
    December 2019
25. WEIGL JAI
    Open flanks in the management of tuberculosis in Germany under the pressure of migration.
    Eur J Clin Microbiol Infect Dis. 2019 Dec 17. pii: 10.1007/s10096-019-03791.
    PubMed     Abstract available
    
    
    
26. KWIZERA R, Katende A, Teu A, Apolot D, et al
    Algorithm-aided diagnosis of chronic pulmonary aspergillosis in low- and middle-income countries by use of a lateral flow device.
    Eur J Clin Microbiol Infect Dis. 2019 Dec 6. pii: 10.1007/s10096-019-03782.
    PubMed    
    
    
    
27. DU J, Zhang L, Ma Y, Chen XY, et al
    Treatment and recurrence on re-treatment tuberculosis patients: a randomized clinical trial and 7-year perspective cohort study in China.
    Eur J Clin Microbiol Infect Dis. 2019 Dec 5. pii: 10.1007/s10096-019-03696.
    PubMed     Abstract available
    
    
    
28. SENTIS A, Vasconcelos P, Machado RS, Cayla JA, et al
    Failure to complete treatment for latent tuberculosis infection in Portugal, 2013-2017: geographic-, sociodemographic-, and medical-associated factors.
    Eur J Clin Microbiol Infect Dis. 2019 Dec 3. pii: 10.1007/s10096-019-03765.
    PubMed     Abstract available
    
    
    November 2019
29. CHEN G, Wang H, Wang Y
    Clinical application of QuantiFERON-TB Gold in-tube in the diagnosis and treatment of tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2019 Nov 30. pii: 10.1007/s10096-019-03768.
    PubMed     Abstract available
    
    
    
30. TANOGLU A, Erdem H, Friedland JS, Almajid FM, et al
    Clinicopathological profile of gastrointestinal tuberculosis: a multinational ID-IRI study.
    Eur J Clin Microbiol Infect Dis. 2019 Nov 22. pii: 10.1007/s10096-019-03749.
    PubMed     Abstract available
    
    
    October 2019
31. KONTSEVAYA I, Werngren J, Holicka Y, Klaos K, et al
    Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review.
    Eur J Clin Microbiol Infect Dis. 2019 Oct 30. pii: 10.1007/s10096-019-03723.
    PubMed     Abstract available
    
    
    
32. SAAD J, Loukil A, Drancourt M
    Bead-captured Mycobacterium tuberculosis for next-generation sequencing diagnosis of uncultured tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2019 Oct 14. pii: 10.1007/s10096-019-03700.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: